Ozempic vs Mounjaro Weight Loss: Which Works Better?

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and tirzepatide are the two most prescribed GLP-1 medications for weight loss, yet they work through different biological pathways and produce measurably different results. Clinical trials show tirzepatide produces greater average weight loss than semaglutide, but individual response varies widely based on genetics, lifestyle, and metabolic factors. PlexusDx helps you access both options and identify which may work best for your body.

Semaglutide vs Tirzepatide: How They Differ at the Cellular Level

Semaglutide works by activating GLP-1 receptors, a single hormone pathway that signals fullness and reduces appetite. Tirzepatide activates both GLP-1 and GIP receptors, creating a dual-hormone signal that suppresses appetite while also improving how your body metabolizes glucose and fat. This dual-receptor activation is why tirzepatide is sometimes called a GIP/GLP-1 receptor agonist, and it fundamentally changes how your metabolism responds to food and energy.

The GIP pathway (glucose-dependent insulinotropic peptide) appears especially important for reducing hunger and boosting metabolic rate in people who carry certain genetic variants. Semaglutide's single-pathway approach remains highly effective for many patients, but it leaves the GIP system unstimulated. Understanding which pathway your body responds to most strongly is where personalized testing becomes valuable.

Clinical Trial Data: Weight Loss Outcomes You Should Know

The STEP trials (semaglutide) showed average weight loss of 15-18% of body weight over 68 weeks at the highest doses tested. The SURMOUNT trials (tirzepatide) demonstrated average weight loss of 21-23% of body weight over similar timeframes, representing roughly 3-5 percentage points more loss than semaglutide. Both are substantially more effective than older weight loss medications, but the tirzepatide advantage appears consistent across multiple trial populations.

Response variability within each medication group is also important to understand: some patients lose 30%+ of body weight on either medication, while others may see more modest results. Sex, baseline metabolic rate, genetic ancestry, and GLP-1 receptor sensitivity all influence individual outcomes. Trial data represents averages, not guarantees, which is why starting with the right medication for your specific biology matters.

Why Individual Genetics Matter More Than Average Trial Results

Your genetic blueprint contains variations in the GLP1R gene (semaglutide's target), the GIPR gene (tirzepatide's additional target), and metabolic genes like FTO and MC4R that predict how strongly you'll respond to either medication. PlexusDx Precision Peptide Genetic Test maps your genetic variants across 14 metabolic pathways and 49 peptides to reveal which medication may produce the strongest response in your body. Someone with a favorable GLP1R rs6923761 variant might see outstanding results on semaglutide alone, while another person with a GIPR rs1800437 variant might respond far better to tirzepatide's dual action.

Clinical trials enroll thousands of people with different genetic backgrounds, which smooths out individual differences. Your body is not an average—it has a specific genetic profile that predicts medication response better than trial statistics alone. This is why two patients on identical doses of the same medication can experience dramatically different weight loss outcomes.

Cost, Access, and How PlexusDx Fits Into Your Decision

PlexusDx offers compounded semaglutide injections starting at $149/month and compounded tirzepatide injections starting at $249/month—both flat pricing regardless of dose level. Your dose may need to go up. Your price won't. All medications come from licensed 503A compounding pharmacies, require no insurance or membership fee, and are HSA/FSA eligible. This pricing structure removes the financial pressure to choose based on cost alone; instead, you can focus on which medication aligns with your metabolism.

PlexusDx also offers GLP-Squared Injection, a dual-compound option combining semaglutide and tirzepatide in one formulation, starting at $249/month for patients who want to activate both pathways simultaneously. After your first month of treatment, the Precision Peptide Genetic Test ($99 add-on) can reveal your genetic response profile, helping you and your provider refine your medication strategy if needed. All treatments are available in all 50 states with no waiting lists or insurance approval delays.

Side Effects and Tolerability: What Differs Between the Two

Both semaglutide and tirzepatide cause nausea, vomiting, and gastrointestinal changes in a significant portion of users, especially during the first 2-4 weeks and when doses increase. Tirzepatide carries a slightly higher rate of gastrointestinal side effects in clinical trials, likely due to its dual-pathway activation. Most side effects diminish over time as the body adjusts, but some patients cannot tolerate GLP-1 medications at all regardless of which one they try.

If side effects prevent you from tolerating injections, PlexusDx offers oral semaglutide (starts at $249/month) and oral tirzepatide (starts at $279/month), though oral formulations require specific timing and may not absorb as efficiently as injections. Your healthcare provider can help monitor tolerability and switch medications if needed without incurring additional membership or setup fees.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does tirzepatide always produce more weight loss than semaglutide?

On average, yes—tirzepatide produces 3-5% more weight loss in clinical trials. However, individual response varies tremendously based on genetics and personal factors. Some people lose significantly more on semaglutide, while others see superior results with tirzepatide. This unpredictability is why genetic testing through PlexusDx can help predict which medication may work best for your specific biology.

What does the GIP receptor actually do in weight loss?

The GIP receptor helps regulate appetite suppression, glucose metabolism, and energy expenditure independently from the GLP-1 pathway. By activating both GLP-1 and GIP receptors, tirzepatide creates a more comprehensive metabolic signal than semaglutide alone. People with genetic variants that enhance GIP responsiveness often see more dramatic weight loss on tirzepatide.

How much does PlexusDx charge, and can I switch medications without extra fees?

PlexusDx charges a flat monthly fee: semaglutide injection starts at $149/month, tirzepatide injection starts at $249/month, with no flat per-compound pricing increases. You can switch between medications anytime without membership fees, setup charges, or insurance requirements. All medications are HSA/FSA eligible and available in all 50 states.

Are compounded semaglutide and tirzepatide as safe as FDA-approved versions?

PlexusDx sources all medications from licensed 503A compounding pharmacies that follow strict quality standards. Compounded medications are not FDA-approved but are prepared under federal oversight and pharmacist supervision. Discuss compounded medication options with your healthcare provider to determine if they're right for you.

How can the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

The Precision Peptide Genetic Test ($99 add-on after first month) analyzes your variants in GLP1R, GIPR, FTO, MC4R, and 45 other genetic markers across 14 metabolic pathways. PlexusDx uses this data to predict which medication—or combination approach like GLP-Squared—aligns best with your genetic response profile, helping optimize your weight loss outcomes.

Do You Lose More Weight with Ozempic or Mounjaro?